Sergey Kalinin Selected Research

vindeburnol

4/2012

The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergey Kalinin Research Topics

Disease

10	Multiple Sclerosis 01/2022 - 11/2005
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 11/2005
5	Alzheimer Disease (Alzheimer's Disease) 03/2017 - 08/2007
3	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 11/2005
3	Neuroinflammatory Diseases 01/2020 - 01/2016
3	Amyloid Plaque 03/2017 - 10/2009
3	Encephalitis (Encephalitis, Rasmussen) 01/2016 - 03/2005
3	Hypertrophy 08/2012 - 03/2011
2	Glioma (Gliomas) 10/2019 - 04/2011
2	Poisoning 05/2019 - 01/2016
2	Disease Progression 12/2012 - 11/2005
2	Inflammation (Inflammations) 03/2011 - 10/2009
2	Vascular Remodeling 01/2011 - 05/2010
1	Relapsing-Remitting Multiple Sclerosis 01/2022
1	Neoplasms (Cancer) 10/2019
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 01/2015
1	Autoimmune Diseases (Autoimmune Disease) 12/2012
1	Chronic Disease (Chronic Diseases) 03/2011
1	dopamine beta hydroxylase deficiency 08/2007
1	Gliosis 12/2006

Drug/Important Bio-Agent (IBA)

4	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2013 - 03/2005
3	bromfenacoum (Ratak)IBA 05/2019 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2006
3	Peptides (Polypeptides)IBA 12/2012 - 05/2010
2	lanthionine ketimineIBA 01/2022 - 01/2019
2	EstersIBA 01/2022 - 01/2019
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2015
2	Amyloid beta-PeptidesIBA 10/2013 - 08/2007
2	Myelin-Oligodendrocyte GlycoproteinIBA 12/2012 - 03/2011
2	Amyloid (Amyloid Fibrils)IBA 08/2012 - 10/2009
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2011 - 05/2010
2	PPAR gammaIBA 10/2009 - 11/2005
2	PPAR deltaIBA 10/2009 - 11/2005
1	Lipocalin-2IBA 01/2022
1	CuprizoneIBA 01/2022
1	lanthionineIBA 01/2022
1	MTOR InhibitorsIBA 10/2019
1	Urea (Carbamide)FDA LinkGeneric 10/2019
1	RodenticidesIBA 05/2019
1	AnticoagulantsIBA 05/2019
1	Semaphorin-3AIBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2017
1	Warfarin (Coumadin)FDA LinkGeneric 01/2016
1	Vitamin K FDA Link 01/2016
1	Thrombin FDA Link 01/2016
1	CoagulantsIBA 01/2016
1	Anesthetics (Anesthetic Agents)IBA 12/2012
1	Sevoflurane (Ultane)FDA LinkGeneric 12/2012
1	VincamineIBA 04/2012
1	vindeburnolIBA 04/2012
1	Transcription Factors (Transcription Factor)IBA 04/2011
1	Dimethyl FumarateIBA 04/2011
1	CytokinesIBA 04/2011
1	LipopolysaccharidesIBA 04/2011
1	NitritesIBA 04/2011
1	InterferonsIBA 04/2011
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2011
1	Angiotensin IIBA 05/2010
1	BradykininIBA 05/2010
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2010
1	Substance PIBA 05/2010
1	Presenilin-1IBA 10/2009
1	GW 742IBA 10/2009
1	Protein Isoforms (Isoforms)IBA 12/2006
1	Messenger RNA (mRNA)IBA 12/2006
1	OccludinIBA 12/2006
1	Pharmaceutical PreparationsIBA 11/2005
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 11/2005
1	LigandsIBA 11/2005
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2005

Therapy/Procedure

1	Therapeutics 01/2022